Skip to main content

Table 3 Incidence rates of End Stage Kidney Failure per 10,000 person years (95% CI) in the QResearch derivation cohort and THIN validation cohort

From: Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney®Scores

   QResearch
derivation cohort
THIN
validation cohort
Women total 3.03 (2.87 to 3.20) 3.03 (2.86 to 3.21)
  35-39 yrs 0.83 (0.65 to 1.07) 0.70 (0.52 to 0.93)
  40-44 yrs 0.95 (0.74 to 1.22) 1.18 (0.93 to 1.49)
  45-49 yrs 1.40 (1.12 to 1.74) 1.41 (1.13 to 1.78)
  50-54 yrs 1.64 (1.33 to 2.02) 1.95 (1.61 to 2.38)
  55-59 yrs 2.56 (2.17 to 3.02) 2.99 (2.55 to 3.50)
  60-64 yrs 4.45 (3.86 to 5.13) 4.29 (3.69 to 4.98)
  65-69 yrs 6.44 (5.68 to 7.30) 7.00 (6.18 to 7.93)
  70-74 yrs 11.6 (10.52 to 12.79) 9.59 (8.58 to 10.72)
Men Total 3.66 (3.48 to 3.85) 3.88 (3.69 to 4.08)
  35-39 yrs 1.01 (0.80 to 1.26) 1.19 (0.95 to 1.48)
  40-44 yrs 1.18 (0.95 to 1.47) 1.55 (1.27 to 1.89)
  45-49 yrs 1.51 (1.22 to 1.86) 1.98 (1.64 to 2.39)
  50-54 yrs 2.30 (1.94 to 2.73) 2.38 (2.00 to 2.84)
  55-59 yrs 3.64 (3.17 to 4.18) 3.58 (3.10 to 4.14)
  60-64 yrs 5.09 (4.44 to 5.82) 5.22 (4.55 to 5.99)
  65-69 yrs 9.48 (8.52 to 10.55) 9.71 (8.70 to 10.83)
  70-74 yrs 14.24 (12.93 to 15.68) 14.36 (12.98 to 15.88)